Comments on:

Court: Can drug companies pay to delay generics?

Back to the article » |
WASHINGTON (AP) — Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent. The Obama administration, backed by consumer groups and the American Medical...

To learn more about commenting on and our community guidelines, please see our comments FAQ.